Literature DB >> 3516263

Reduced recurrence-free survival after reduced doses of adjuvant chemotherapy in breast cancer: are groups selected after randomization comparable?

L E Rutqvist, A Wallgren, A C Wennerholm.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3516263     DOI： 10.1007/bf01886735

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  4 in total

1.  The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with disease-free survival.

Authors:  C Redmond; B Fisher; H S Wieand
Journal:  Cancer Treat Rep       Date:  1983-06

2.  Dose: a critical factor in cancer chemotherapy.

Authors:  E Frei; G P Canellos
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

3.  Dose-response effect of adjuvant chemotherapy in breast cancer.

Authors:  G Bonadonna; P Valagussa
Journal:  N Engl J Med       Date:  1981-01-01       Impact factor: 91.245

4.  Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer.

Authors:  G Bonadonna; P Valagussa; A Rossi; G Tancini; C Brambilla; M Zambetti; U Veronesi
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.